Barriers and Variations in Cancer Diagnosis: A Cross-Sectional Analysis of Patient Journeys and Healthcare Provider Timelines in Public Health Systems of Chile, Colombia, and Ecuador - Top-Institutions - MDSpire

Barriers and Variations in Cancer Diagnosis: A Cross-Sectional Analysis of Patient Journeys and Healthcare Provider Timelines in Public Health Systems of Chile, Colombia, and Ecuador

  • By

  • María-Luisa Vázquez

  • Pamela Eguiguren

  • Amparo-Susana Mogollón-Pérez

  • Andrés Peralta

  • Josep M Borràs

  • Ignacio Aznar-Lou

  • Signe Smith Jervelund

  • Carol Cardozo

  • Samar Benthami-Zarhouni

  • Iván Dueñas-Espín

  • María Luisa Garmendia

  • Sónia Dias

  • Ingrid Vargas

  • February 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Cancer Epidemiology
    • Health Services Research

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Cancer Health Disparities
    • Health Systems Research

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Oncology
    • Cancer Epidemiology
    • Health Services Research

  • #4

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Research
    • Health Services Research
    • Implementation Science

  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Cancer Health Disparities
    • Health Services Research

Original Source(s)

Barriers and Variations in Cancer Diagnosis: A Cross-Sectional Analysis of Patient Journeys and Healthcare Provider Timelines in Public Health Systems of Chile, Colombia, and Ecuador

  • by María-Luisa Vázquez, Pamela Eguiguren, Amparo-Susana Mogollón-Pérez, Andrés Peralta, Josep M Borràs, Ignacio Aznar-Lou, Signe Smith Jervelund, Carol Cardozo, Samar Benthami-Zarhouni, Iván Dueñas-Espín, María Luisa Garmendia, Sónia Dias, Ingrid Vargas

  • February 26, 2026

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison